Page last updated: 2024-10-21

vanilmandelic acid and Intracranial Arteriosclerosis

vanilmandelic acid has been researched along with Intracranial Arteriosclerosis in 1 studies

Vanilmandelic Acid: A 3-O-methyl ether of 3,4-dihydroxymandelic acid. It is an end-stage metabolite of CATECHOLAMINES; EPINEPHRINE; and NOREPINEPHRINE.
vanillylmandelic acid : An aromatic ether that is the 3-O-methyl ether of 3,4-dihydroxymandelic acid.

Intracranial Arteriosclerosis: Vascular diseases characterized by thickening and hardening of the walls of ARTERIES inside the SKULL. There are three subtypes: (1) atherosclerosis with fatty deposits in the ARTERIAL INTIMA; (2) Monckeberg's sclerosis with calcium deposits in the media and (3) arteriolosclerosis involving the small caliber arteries. Clinical signs include HEADACHE; CONFUSION; transient blindness (AMAUROSIS FUGAX); speech impairment; and HEMIPARESIS.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kawiak, W1
Stelmasiak, Z1

Other Studies

1 other study available for vanilmandelic acid and Intracranial Arteriosclerosis

ArticleYear
[Urinary excretion of 3-methoxy-4-hydroxy-mandelic acid (VMA) in patients with subarachnoid hemorrhage].
    Neurologia i neurochirurgia polska, 1972, Volume: 6, Issue:3

    Topics: Adult; Aged; Carotid Arteries; Cerebral Angiography; Humans; Hypertension; Intracranial Arterioscler

1972